CD274 and osteosarcoma: Congruent with the in vitro and in vivo characterization in GBM models, CARζ/CPR41BB cells consistently showed robust activity against osteosarcoma without evident toxicities from continued engagement of PD-L1 in the presence of widespread tumor burden.